Long-Term Efficacy and Safety of Zanubrutinib in Patients with Relapsed/Refractory (R/R) Marginal Zone Lymphoma (MZL): Final Analysis of the Magnolia (BGB-3111-214) Trial

S Opat, A Tedeschi, B Hu, KM Linton, P McKay, H Chan, J Jin, MY Sun, M Sobieraj-Teague, PL Zinzani, PJ Browett, XY Ke, CA Portell, C Thieblemont, K Ardeshna, F Bijou, P Walker, E Hawkes, SJ Ho, KS ZhouZY Liang, JF Xu, C Tankersley, R Delarue, M Co, J Trotman

Research output: Contribution to journalMeeting Abstractpeer-review

Original languageEnglish
Number of pages4
Publication statusPublished - 15 Nov 2022

Cite this